{"id":"CHEMBL1161633","canonicalSmiles":"[O-][Cl+2]([O-])O","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chlorate"],"crossReferences":{"drugbank":["DB14150"],"chEBI":["17322"]},"childChemblIds":["CHEMBL1559268","CHEMBL3188561"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200659","canonicalSmiles":"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O.O=C(O)/C=C\\C(=O)O","drugType":"Small molecule","blackBoxWarning":true,"name":"ENALAPRIL MALEATE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL578","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ednyt","Enalapril Maleate","Enapren","Epaned","Epaned kit","Innovace","Pralenal 10","Pralenal 2.5","Pralenal 20","Pralenal 5","Renitec","Vasotec","Xanef"],"synonyms":["Enalapril Maleate","MK-421"],"crossReferences":{"DailyMed":["enalapril%20maleate","enalapril%20maleate"],"PubChem":["56424090","855584","56424090","855584"],"chEBI":["4785"]},"count":5,"approvedIndications":["EFO_0000537"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and is indicated for hypertension and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200736","canonicalSmiles":"O=C([O-])[O-].[Mg+2]","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM CARBONATE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Andrews","Mag Carb","Mag Carb Arom","Mag Carb Co","Magnesite"],"synonyms":["C.I. 77713","E504","Magnesium Carbonate","NSC-83511"],"crossReferences":{"DrugCentral":["4288","4288"],"Wikipedia":["Magnesium_carbonate","Magnesium_carbonate"],"DailyMed":["magnesium%20carbonate","magnesium%20carbonate"],"drugbank":["DB09481"],"chEBI":["31793"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990."}
{"id":"CHEMBL1200796","canonicalSmiles":"O.O=P1(N(CCCl)CCCl)NCCCO1","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOPHOSPHAMIDE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL88","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cyclophosphamide","Cytoxan","Cytoxan (Lyophilized)","Endoxana","Lyophilized Cytoxan","Neosar"],"synonyms":["B-518","Cyclophosphamide","Cyclophosphamide anhydrous","Cyclophosphamide hydrate","Cyclophosphamide monohydrate","NSC-26271"],"crossReferences":{"DailyMed":["cyclophosphamide","cyclophosphamide"],"PubChem":["144203651","144208701","144210847","170464624","17389078","26747956","50086596","144203651","144208701","144210847","170464624","17389078","26747956","50086596"],"chEBI":["4026"]},"count":162,"approvedIndications":["EFO_0003869","EFO_0000574","EFO_0001378","EFO_0000183","EFO_0000305"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and has 5 approved and 157 investigational indications."}
{"id":"CHEMBL1201098","canonicalSmiles":"CO[C@@]1(NC(=O)C2SC(=C(C(N)=O)C(=O)[O-])S2)C(=O)N2C(C(=O)[O-])=C(CSc3nnnn3C)CS[C@@H]21.[Na+].[Na+]","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFOTETAN DISODIUM","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL474579","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cefotan","Cefotetan","Yamatetan"],"synonyms":["Cefotetan Disodium","Cefotetan Sodium","Cefotetan disodium salt","YM-09330"],"crossReferences":{"DailyMed":["cefotetan%20disodium","cefotetan%20disodium"],"chEBI":["34617"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985 and has 1 investigational indication."}
{"id":"CHEMBL1201581","drugType":"Antibody","blackBoxWarning":true,"name":"INFLIXIMAB","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Inflectra","Remicade","Remsima"],"synonyms":["ABP 710","BOW015","Infliximab","NI-071","TA-650","cA2"],"crossReferences":{"DrugCentral":["4974","4974"],"Wikipedia":["Infliximab","Infliximab"],"DailyMed":["infliximab","infliximab"]},"count":41,"approvedIndications":["EFO_0000729","EFO_0000685","EFO_0003898","EFO_0003778","EFO_0000676","EFO_0000540","EFO_0000384"],"linkedTargets":{"rows":["ENSG00000232810"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_1000710","EFO_0003780","EFO_0000756","EFO_0003778","EFO_0000540","EFO_0004246","MONDO_0001718","MONDO_0008903","EFO_0000676","EFO_0003761","HP_0003419","EFO_0004616","EFO_0009321","EFO_0004276","Orphanet_379","Orphanet_797","MONDO_0013730","EFO_0000685","EFO_0002687","HP_0002039","EFO_0003898","EFO_0000384","EFO_1000784","EFO_0000537","EFO_1001231","EFO_0004220","EFO_0007460","MONDO_0003937","EFO_0000398","EFO_0005297","EFO_0001359","EFO_0000706","EFO_0000341","EFO_0003767","EFO_0004775","EFO_0003872"],"count":37},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and has 7 approved and 34 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1212979","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](CF)[C@@H](O)[C@H]1O","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1212979","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03716"],"chEBI":["12060"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232903","canonicalSmiles":"O=P(O)(O)OC(CO)CO","drugType":"Small molecule","blackBoxWarning":false,"name":"GLYCERYLPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["29217795","29217795"],"drugbank":["DB01779"],"chEBI":["17270"]},"childChemblIds":["CHEMBL3707206"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234490","canonicalSmiles":"CCNc1nc(NC(C)(C)C)nc(SC)n1","drugType":"Small molecule","blackBoxWarning":false,"name":"TERBUTRYNE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144209280","144213458","26757718","47193751","144209280","144213458","26757718","47193751"],"drugbank":["DB08215"],"chEBI":["44156"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236936","canonicalSmiles":"O=C(O)CCCCN(CCc1ccccc1OCc1ccc(CCc2ccccc2)cc1)Cc1ccc(C(=O)O)cc1","drugType":"Small molecule","blackBoxWarning":false,"name":"Cinaciguat","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY 58-2667","Cinaciguat"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL135","canonicalSmiles":"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O","drugType":"Small molecule","blackBoxWarning":true,"name":"ESTRADIOL","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adgyn Estro","Alora","Aquagen","Bedol","Climara","Climara Pro","Dermestril 100","Dermestril 25","Dermestril 50","Dermestril Septem 25","Dermestril Septem 50","Dermestril Septem 75","Divigel","E-Cypionate","Elestrim","Elestrin","Elleste Solo","Elleste Solo MX 40","Elleste Solo MX 80","Esclim","Estrace","Estraderm","Estraderm MX 100","Estraderm MX 25","Estraderm MX 50","Estraderm MX 75","Estraderm TTS 100","Estraderm TTS 25","Estraderm TTS 50","Estradiol","Estrasorb","Estring","Estrogel","Evamist","Evorel 100","Evorel 25","Evorel 50","Evorel 75","FemSeven 100","FemSeven 50","FemSeven 75","Fematrix 40","Fematrix 80","Fempatch","Gvnodiol","Gynodiol","Gynogen","Imvexxy","Innofem","Menorest 37.5","Menorest 50","Menorest 75","Menoring 50","Menostar","Minivelle","Oestradiol","Progynova TS","Sandrena","Vagifem","Vagifem 18","Vagifem 8","Vivelle","Vivelle-Dot","Zumenon"],"synonyms":["Agofollin","Alfatradiol","Depo-Estradiol","Destradiol","Dihydrotheelin","Dihydroxyestrin","Estradiol","Estradiol Hemihydrate","Estradiol hemihydrate","Estrasorb","Gynergon","Gynoestryl","NSC-20293","NSC-9895","Oestradiol","WC-3011","WC3011"],"crossReferences":{"Wikipedia":["Estradiol","Estradiol"],"DailyMed":["estradiol","estradiol"],"PubChem":["144204699","144209255","144210608","17389898","26753050","26753051","26753052","29215115","29215116","29215117","50105619","50105620","50124031","56422158","8139865","90341590","144204699","144209255","144210608","17389898","26753050","26753051","26753052","29215115","29215116","29215117","50105619","50105620","50124031","56422158","8139865","90341590"],"drugbank":["DB00783"],"chEBI":["16469"]},"count":37,"linkedTargets":{"rows":["ENSG00000091831"],"count":1},"linkedDiseases":{"rows":["MONDO_0001410","EFO_0001065","EFO_0007453","MONDO_0007254","HP_0031217","EFO_0000305","EFO_0002950","EFO_1001271","MONDO_0002146","EFO_0004714","MONDO_0041161","HP_0002907","EFO_0003103","EFO_1001375","HP_0008209","EFO_1000645","EFO_0003761","EFO_0000692","EFO_0000545","EFO_1000906","EFO_0003821","EFO_0000180","EFO_0001358","EFO_0000319","EFO_0004243","EFO_0009867","EFO_0000660","MONDO_0008315","EFO_0001663","EFO_0000537","GO_0007568","MONDO_0100096","EFO_0000764","HP_0100607","EFO_1000766","Orphanet_881","EFO_1000859","EFO_0001360","EFO_0005411","EFO_0003922","EFO_0004710"],"count":41},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1975 and has 37 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL139020","canonicalSmiles":"O=C(O)Cc1cccc([N+](=O)[O-])c1","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL139020","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08193"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1420319","canonicalSmiles":"CC(C)(C)c1ccc(Oc2ccc(N)cn2)cc1","drugType":"Small molecule","blackBoxWarning":false,"name":"CB-103","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CB-103","Cb-103"],"crossReferences":{"PubChem":["26730448","26730448"],"drugbank":["DB15279"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1439973","canonicalSmiles":"CC(C)(O)C(Cl)(Cl)Cl","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOROBUTANOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chloretone"],"synonyms":["Chlorbutol","Chlorobutanol","NSC-44794","Trichlorisobutylalcohol"],"crossReferences":{"PubChem":["144205182","170465458","29215323","29215324","144205182","170465458","29215323","29215324"],"drugbank":["DB11386"]},"count":1,"approvedIndications":["HP_0002018"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for nausea."}
{"id":"CHEMBL1441059","canonicalSmiles":"CC(C)(C)NCC(O)c1ccc(O)c(CO)c1.CC(C)(C)NCC(O)c1ccc(O)c(CO)c1.O=S(=O)(O)O","drugType":"Small molecule","blackBoxWarning":true,"name":"ALBUTEROL SULFATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL714","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Accuneb","Albuterol Sulfate","Proair","Proair Hfa","Proair digihaler","Proair respiclick","Proventil","Proventil-Hfa","Ventolin","Ventolin Hfa","Ventolin Rotacaps","Volmax","Vospire Er"],"synonyms":["Albuterol Sulfate","NSC-289928","R03AC02","R03CC02","SCH-13949W SULFATE","Salbutamol Sulfate"],"crossReferences":{"DailyMed":["albuterol%20sulfate","albuterol%20sulfate"],"PubChem":["50107002","50107002"]},"count":5,"approvedIndications":["EFO_0000270","EFO_0000341"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for asthma and chronic obstructive pulmonary disease and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL146506","canonicalSmiles":"C/C(=C\\c1ccc(OCCN2CCOCC2)cc1)c1ccc2c(c1)C(C)(C)CCC2(C)C","drugType":"Small molecule","blackBoxWarning":false,"name":"MOFAROTENE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mofarotene","Ro-408757"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL14687","canonicalSmiles":"CCCO","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPANOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ethylcarbinol","Propan-1-ol","Propanol"],"crossReferences":{"Wikipedia":["1-Propanol","1-Propanol"],"drugbank":["DB03175"],"chEBI":["28831"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1496","canonicalSmiles":"CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)O","drugType":"Small molecule","blackBoxWarning":false,"name":"ROSUVASTATIN","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Rosuvastatin","ZD-4522","ZD4522"],"crossReferences":{"Wikipedia":["Rosuvastatin","Rosuvastatin"],"DailyMed":["rosuvastatin%20calcium","rosuvastatin%20calcium"],"drugbank":["DB01098"],"chEBI":["38545"]},"childChemblIds":["CHEMBL1744447"],"count":66,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000113161"],"count":1},"linkedDiseases":{"rows":["EFO_0009505","EFO_0000275","EFO_1001249","MONDO_0007254","EFO_0005669","EFO_1000657","EFO_0003774","EFO_1001461","EFO_0000266","EFO_0000373","HP_0100545","EFO_1001951","EFO_0003913","EFO_0003914","EFO_0004211","EFO_0005226","EFO_0008585","EFO_0002690","EFO_0003144","EFO_0000712","EFO_1000807","Orphanet_391665","EFO_0003761","EFO_0003047","EFO_0000400","EFO_0000717","EFO_0000407","EFO_0002617","EFO_0000616","EFO_0000685","HP_0002140","HP_0003124","EFO_0002687","EFO_0001645","EFO_0000180","EFO_0000319","EFO_0004911","EFO_0003060","Orphanet_309005","EFO_0000537","EFO_0000311","EFO_0000195","EFO_1001150","HP_0100806","EFO_0000589","EFO_0009426","MONDO_0021661","EFO_0000764","EFO_0008583","EFO_0003907","EFO_0000612","EFO_0001360","EFO_0000668","EFO_0005672"],"count":54},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and is indicated for cardiovascular disease and has 65 investigational indications."}
{"id":"CHEMBL1733174","canonicalSmiles":"CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1.O=C(O)CC(O)(CC(=O)O)C(=O)O","drugType":"Small molecule","blackBoxWarning":false,"name":"MOSAPRIDE CITRATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL60889","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AS-4370","Gasmotin","Mosapride citrate"],"crossReferences":{"PubChem":["144205427","170466008","49681606","144205427","170466008","49681606"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1738757","canonicalSmiles":"CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1","drugType":"Small molecule","blackBoxWarning":false,"name":"REBASTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["DP-1919"],"synonyms":["DCC-2036","DCC-2036 FREE BASE","DP-1919","Rebastinib"],"crossReferences":{"PubChem":["137276016","137276016"],"drugbank":["DB13005"],"chEBI":["62166"]},"childChemblIds":["CHEMBL2107833"],"count":2,"linkedTargets":{"rows":["ENSG00000097007"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000304","EFO_0000339"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2104445","canonicalSmiles":"CCOc1c(N)c2c(c(OCC)c1OCC)C(C1c3c(cc4c(c3OC)OCO4)CCN1C)OC2=O","drugType":"Small molecule","blackBoxWarning":false,"name":"TRITOQUALINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hypostamine"],"synonyms":["L-554","Tritoqualine"],"crossReferences":{"drugbank":["DB13711"]},"count":1,"approvedIndications":["EFO_0003785"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for allergy."}
{"id":"CHEMBL2104462","canonicalSmiles":"COc1ccc2c(=O)c3ccccc3oc2c1CN1CCCCC1","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPIXANOX","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mepixanox"],"crossReferences":{"drugbank":["DB13579"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104970","canonicalSmiles":"NC(=O)C1=C(O)C[C@@H]2C[C@@H]3Cc4cccc(O)c4C(=O)C3=C(O)[C@]2(O)C1=O","drugType":"Small molecule","blackBoxWarning":false,"name":"INCYCLINIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Metastat"],"synonyms":["COL-3","Incyclinide","NSC-683551"],"crossReferences":{"drugbank":["DB11647"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105359","canonicalSmiles":"C=C1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO","drugType":"Small molecule","blackBoxWarning":false,"name":"PREDNYLIDENE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methylenprednisolone","Prednylidene"],"crossReferences":{"drugbank":["DB13208"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2105736","canonicalSmiles":"CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(C)nc1C.O=S(=O)(O)c1ccccc1","drugType":"Small molecule","blackBoxWarning":false,"name":"EPELSIBAN BESYLATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2037511","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Epelsiban Besylate","GSK-557296B","GSK557296B"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2106399","canonicalSmiles":"CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O","drugType":"Small molecule","blackBoxWarning":false,"name":"KITASAMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acetylkitasamycin","Kitasamycin","Kitasamycin Tartrate"],"crossReferences":{"drugbank":["DB09309"],"chEBI":["34812"]},"childChemblIds":["CHEMBL2355304"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108512","drugType":"Unknown","blackBoxWarning":false,"name":"HEPATITIS B IMMUNE GLOBULIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["BayHep B","H-BIG","Hep-B-Gammagee","Liberim HB"],"synonyms":["Hepatitis B Immune Globulin","Hepatitis b immunoglobulin"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL216973","canonicalSmiles":"Nc1cccc2cnccc12","drugType":"Small molecule","blackBoxWarning":false,"name":"5-Aminoisoquinoline","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5-Aminoisoquinoline"],"crossReferences":{"PubChem":["4248661","4248661"],"drugbank":["DB04605"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2181776","canonicalSmiles":"Cn1c(-c2ccccn2)c(C2CCCC2)c2ccc(C(=O)NC3(C(=O)Nc4ccc(/C=C/C(=O)O)cc4)CCC3)cc21","drugType":"Small molecule","blackBoxWarning":false,"name":"BILB-1941","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BILB 1941","BILB-1941ZW","Bilb-1941"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL248643","canonicalSmiles":"Oc1ccc(-c2cnc3ccc4ccncc4c3c2)cc1","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL248643","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03623"],"chEBI":["40444"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL267648","canonicalSmiles":"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21","drugType":"Small molecule","blackBoxWarning":false,"name":"PEFLOXACIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["1589 RB","EU-5306","Pefloxacin"],"crossReferences":{"Wikipedia":["Pefloxacin","Pefloxacin"],"PubChem":["174006962","174006962"],"drugbank":["DB00487"],"chEBI":["50199"]},"childChemblIds":["CHEMBL3763640","CHEMBL1428564"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL267894","canonicalSmiles":"CCC1(CCC(C)C)C(=O)N=C(O)NC1=O","drugType":"Small molecule","blackBoxWarning":false,"name":"AMOBARBITAL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Norway"],"classes":["Misuse"],"year":1980},"tradeNames":["Amytal"],"synonyms":["Amobarbital","Amylobarbitone","Pentymal"],"crossReferences":{"Wikipedia":["Amobarbital","Amobarbital"],"PubChem":["144206419","144206419"],"drugbank":["DB01351"],"chEBI":["2673"]},"childChemblIds":["CHEMBL2105941"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in Norway  in 1980 due to Misuse."}
{"id":"CHEMBL285674","canonicalSmiles":"Clc1ccc2c(c1)C(c1ccccc1)=NCc1nncn1-2","drugType":"Small molecule","blackBoxWarning":true,"name":"ESTAZOLAM","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Estazolam","Eurodin","Prosom"],"synonyms":["ABBOTT-47631","Estazolam","Estazolam civ","NSC-290818"],"crossReferences":{"Wikipedia":["Estazolam","Estazolam"],"DailyMed":["estazolam","estazolam"],"PubChem":["144206162","50113063","144206162","50113063"],"drugbank":["DB01215"],"chEBI":["4858"]},"count":1,"approvedIndications":["EFO_0004698"],"linkedTargets":{"rows":["ENSG00000022355","ENSG00000182256","ENSG00000011677","ENSG00000113327","ENSG00000151834","ENSG00000163285","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["EFO_0004698"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990 and is indicated for insomnia. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3039529","canonicalSmiles":"C#Cc1cnc2nc(O)n(C(CC)CC)c2n1","drugType":"Small molecule","blackBoxWarning":false,"name":"TIRASEMTIV","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CK-2017357","Tirasemtiv"],"crossReferences":{"drugbank":["DB12209"]},"count":4,"linkedTargets":{"rows":["ENSG00000130595","ENSG00000101470","ENSG00000130598"],"count":3},"linkedDiseases":{"rows":["EFO_0000253","EFO_0004991","EFO_0003876","EFO_0004265"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3039531","canonicalSmiles":"Cc1c(F)cccc1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)[C@H]2CCCNC2)c1O","drugType":"Small molecule","blackBoxWarning":false,"name":"DANIRIXIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Danirixin","GSK-1325756B","GSK1325756","GSK1325756B"],"crossReferences":{"drugbank":["DB11922"]},"count":3,"linkedTargets":{"rows":["ENSG00000180871"],"count":1},"linkedDiseases":{"rows":["EFO_0000341","EFO_0000763"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3216899","canonicalSmiles":"Cc1cc(Cn2nnc3c(-c4ccco4)nc(N)nc32)ccc1N.Cl.Cl","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3216899","maximumClinicalTrialPhase":0,"parentId":"CHEMBL447664","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3249110","canonicalSmiles":"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(CCO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1","drugType":"Small molecule","blackBoxWarning":false,"name":"13-DEOXYDOXORUBICIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["13-deoxydoxorubicin","GPX-100","Gpx-100"],"crossReferences":{"drugbank":["DB05706"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3301586","drugType":"Antibody","blackBoxWarning":false,"name":"CLIVATUZUMAB TETRAXETAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Clivatucyn"],"synonyms":["Clivatuzumab tetraxetan","HPAM-4","HPAM4","IGG-DOTA","IMMU-107"],"count":1,"linkedTargets":{"rows":["ENSG00000215182"],"count":1},"linkedDiseases":{"rows":["EFO_0002618"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3301593","canonicalSmiles":"Nc1ccc(C#Cc2cnn3c(C(F)(F)F)cc(-c4ccc(C(F)(F)F)cc4)nc23)cn1","drugType":"Small molecule","blackBoxWarning":false,"name":"DECOGLURANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Decoglurant","RG-1578","RO-4995819"],"crossReferences":{"drugbank":["DB11923"]},"count":1,"linkedTargets":{"rows":["ENSG00000164082","ENSG00000198822"],"count":2},"linkedDiseases":{"rows":["MONDO_0002009","EFO_0003761"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL333964","canonicalSmiles":"N[C@@H](Cn1cc(Br)c(=O)[nH]c1=O)C(=O)O","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL333964","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04000"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545031","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-1029","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-1029"],"count":1,"linkedTargets":{"rows":["ENSG00000183134"],"count":1},"linkedDiseases":{"rows":["EFO_0000270"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545076","canonicalSmiles":"Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-2584702","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY 2584702","LY-2584702","LY2584702"],"crossReferences":{"drugbank":["DB12690"]},"childChemblIds":["CHEMBL3911801","CHEMBL3909070"],"count":3,"linkedTargets":{"rows":["ENSG00000108443"],"count":1},"linkedDiseases":{"rows":["EFO_1001901","EFO_0003060","EFO_0000311"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL363295","canonicalSmiles":"CC(CC(c1ccccc1)c1ccccc1)NC(C)(C)C","drugType":"Small molecule","blackBoxWarning":false,"name":"TERODILINE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Germany"," Spain"," United Kingdom"],"classes":["Cardiotoxicity"],"year":1991},"tradeNames":[],"synonyms":["Terodiline"],"crossReferences":{"Wikipedia":["Terodiline","Terodiline"],"drugbank":["DB13725"]},"childChemblIds":["CHEMBL539770"],"linkedTargets":{"rows":["ENSG00000075461","ENSG00000157445","ENSG00000100346","ENSG00000151067","ENSG00000166862","ENSG00000148408","ENSG00000198216","ENSG00000167535","ENSG00000105605","ENSG00000006116","ENSG00000168539","ENSG00000007402","ENSG00000180720","ENSG00000102001","ENSG00000151062","ENSG00000141837","ENSG00000130433","ENSG00000006283","ENSG00000075429","ENSG00000108878","ENSG00000196557","ENSG00000153956","ENSG00000181072","ENSG00000067191"],"count":24},"linkedDiseases":{"rows":["HP_0000020","HP_0000103"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1986. It was withdrawn in Germany,  Spain and  United Kingdom initially in 1991 due to Cardiotoxicity."}
{"id":"CHEMBL363498","canonicalSmiles":"N#Cc1cc(O)cc2cc(-c3ccc(O)cc3)oc12","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL363498","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07198"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833370","canonicalSmiles":"Cc1cc(O)cc(C)c1C[C@H](NC(=O)[C@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(N)=O","drugType":"Protein","blackBoxWarning":false,"name":"ELAMIPRETIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Elamipretide","MTP 131","MTP-131","RX 31","RX-31","SS 31","SS-31"],"crossReferences":{"drugbank":["DB11981"]},"childChemblIds":["CHEMBL4298161"],"count":8,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL404215","canonicalSmiles":"OC(CCN1CCCCC1)(c1ccccc1)c1ccccc1","drugType":"Small molecule","blackBoxWarning":false,"name":"PRIDINOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["C-238","Pridinol","Pridinol Mesilate"],"crossReferences":{"Wikipedia":["Pridinol","Pridinol"],"PubChem":["144203573","170465865","4252736","50100154","50104209","50104210","50104211","84992","144203573","170465865","4252736","50100154","50104209","50104210","50104211","84992"],"drugbank":["DB13642"],"chEBI":["75247"]},"childChemblIds":["CHEMBL1528011"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297498","canonicalSmiles":"FC(F)(F)c1cccc(C2=CCN(CCc3ccc4ccncc4c3)CC2)c1","drugType":"Small molecule","blackBoxWarning":false,"name":"SSR-150106","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SSR-150106","SSR-150106XB","SSR150106","SSR150106XB","Ssr-150106","Ssr150106"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297869","drugType":"Unknown","blackBoxWarning":false,"name":"COAGULATION FACTOR VIIA RECOMBINANT HUMAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Activated recombinant human factor vii","Coagulation factor viia (recombinant)","Eptacog Alfa (Activated)","Eptacog beta (activated)","Recombinant activated factor vii"],"count":5,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4297898","drugType":"Unknown","blackBoxWarning":false,"name":"AVIDIN PERIODATE OXIDIZED","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Avidin periodate oxidized","Avidinox"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297904","drugType":"Unknown","blackBoxWarning":false,"name":"BAY-1093884","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY-1093884","BAY1093884","Bay-1093884","Bay1093884"],"count":3,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4298001","drugType":"Antibody","blackBoxWarning":false,"name":"CETRELIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cetrelimab","JNJ-63723283","Jnj-63723283"],"count":2,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL437557","canonicalSmiles":"CN(C)C(=O)[C@@H]([C@H]1CC[C@H](c2ccc3ncnn3c2)CC1)[C@H](N)C(=O)N1CCC(F)(F)C1","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL437557","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07092"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL445245","canonicalSmiles":"CCc1ccsc1-c1ccc(O)c(O)c1","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL445245","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08718"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL447664","canonicalSmiles":"Cc1cc(Cn2nnc3c(-c4ccco4)nc(N)nc32)ccc1N","drugType":"Small molecule","blackBoxWarning":false,"name":"VIPADENANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIIB-014","CEB-4520","V-2006","V2006","VER-11135","VER-A-00-11","VER-A-00049","VER-A00-11","VER-A00049","VER-ADO-49","Vipadenant"],"crossReferences":{"drugbank":["DB06625"]},"childChemblIds":["CHEMBL3216899","CHEMBL461006"],"count":1,"linkedTargets":{"rows":["ENSG00000128271"],"count":1},"linkedDiseases":{"rows":["EFO_0002508"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL455917","canonicalSmiles":"OC(O)C(Cl)(Cl)Cl","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORAL HYDRATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Noctec","SK-Chloral Hydrate"],"synonyms":["Chloral Hydrate","NSC-3210"],"crossReferences":{"Wikipedia":["Chloral_hydrate","Chloral_hydrate"],"PubChem":["144205167","144207308","170465484","29215298","144205167","144207308","170465484","29215298"],"drugbank":["DB01563"],"chEBI":["28142"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL459","canonicalSmiles":"C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLDOPA","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aldomet","Dopamet","Lederdopa","Medomet","Metalpha 250","Metalpha 500","Methyldopa"],"synonyms":["Alpha-Methyldopa","BAYER-1440L","J9.247I","MK-351","Methyldopa","Methyldopa (levorotatory)","Methyldopa hydrate","Methyldopa sesquihydrate","NSC-169916"],"crossReferences":{"Wikipedia":["Methyldopa","Methyldopa"],"TG-GATEs":["56","56"],"DailyMed":["methyldopa","methyldopa"],"PubChem":["11113581","124886927","144209808","50104474","8139902","90341702","11113581","124886927","144209808","50104474","8139902","90341702"],"drugbank":["DB00968"],"chEBI":["61058"]},"childChemblIds":["CHEMBL4063475","CHEMBL1591707"],"count":3,"approvedIndications":["EFO_0000537"],"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000150594"],"count":3},"linkedDiseases":{"rows":["EFO_0001359","EFO_0000668","EFO_0000537"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1962 and is indicated for hypertension and has 2 investigational indications."}
{"id":"CHEMBL500779","canonicalSmiles":"Nc1n[nH]c2ccc(-c3ccccc3)cc12","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL500779","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07161"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL522987","canonicalSmiles":"Cc1cc(F)ccc1[C@H]1CNCCN1C(=O)N(C)[C@H](C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1","drugType":"Small molecule","blackBoxWarning":false,"name":"VESTIPITANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW-597599","Vestipitant"],"crossReferences":{"Wikipedia":["Vestipitant","Vestipitant"],"drugbank":["DB11949"]},"childChemblIds":["CHEMBL2104992"],"count":6,"linkedTargets":{"rows":["ENSG00000115353"],"count":1},"linkedDiseases":{"rows":["HP_0000360","MONDO_0002050","EFO_0004888"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL54277","canonicalSmiles":"O=[N+]([O-])c1ccc2cn[nH]c2c1","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL54277","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11113657","56423145","8139969","11113657","56423145","8139969"],"drugbank":["DB03100"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL596","canonicalSmiles":"CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1","drugType":"Small molecule","blackBoxWarning":true,"name":"FENTANYL","yearOfFirstApproval":1968,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Abstral","Actiq","Breakyl","Duragesic","Duragesic-100","Duragesic-12","Duragesic-25","Duragesic-37","Duragesic-50","Duragesic-75","Durogesic","Durogesic DTrans","Effentora","Fencino","Fentalis Reservoir","Fentanyl-100","Fentanyl-12","Fentanyl-25","Fentanyl-37","Fentanyl-50","Fentanyl-62","Fentanyl-75","Fentanyl-87","Fentora","Ionsys","Leptanal","Matrifen","Mezolar Matrix","Mylafent","Opiodur","Oralet","Osmach","Osmanil","Pecfent","Recivit","Sublimaze","Subsys","Tilofyl","Victanyl","Yemex"],"synonyms":["AD 923","AD-923","Fentanyl","Fentanyl cii","Fentora","IDS-NF-001","Innovar","Ionsys","N02AB03","R 4263"],"crossReferences":{"Wikipedia":["Fentanyl","Fentanyl"],"DailyMed":["fentanyl","fentanyl%20citrate","fentanyl%20hydrochloride","fentanyl","fentanyl%20citrate","fentanyl%20hydrochloride"],"PubChem":["144206164","50113065","144206164","50113065"],"drugbank":["DB00813"],"chEBI":["119915"]},"childChemblIds":["CHEMBL688","CHEMBL1201159"],"count":25,"approvedIndications":["HP_0012532","EFO_0003843","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_1001139","EFO_0003777","EFO_0006834","EFO_0000555","EFO_1001905","EFO_0004992","EFO_0009267","EFO_0002950","EFO_0009727","HP_0100543","EFO_0003931","EFO_0002506","EFO_0007202","MONDO_0021666","EFO_0004616","HP_0003419","EFO_0009870","EFO_0005762","EFO_0002618","EFO_0009508","EFO_0000685","HP_0002093","EFO_0001074","HP_0012532","EFO_0003843","EFO_0000311","EFO_0000713","EFO_0003841","EFO_0009842","HP_0002045","EFO_0001421","EFO_0004273","EFO_1001373","EFO_0000341","EFO_0005611","EFO_0003918"],"count":36},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1968 and has 3 approved and 22 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL80257","canonicalSmiles":"O=C(O)[C@H]1CCCN1","drugType":"Small molecule","blackBoxWarning":false,"name":"D-PROLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-Proline","Pyrrolidine-2-Carboxylic Acid"],"crossReferences":{"PubChem":["26756694","26756694"],"drugbank":["DB02853"],"chEBI":["16313"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL9","canonicalSmiles":"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21","drugType":"Small molecule","blackBoxWarning":true,"name":"NORFLOXACIN","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Baccidal","Chibroxin","Noroxin","Quinabic","Utinor"],"synonyms":["MK-366","Norfloxacin","Noroxin"],"crossReferences":{"Wikipedia":["Norfloxacin","Norfloxacin"],"PubChem":["11112831","124882669","144204233","144206991","170464769","174007429","26746929","855614","11112831","124882669","144204233","144206991","170464769","174007429","26746929","855614"],"drugbank":["DB01059"],"chEBI":["100246"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and has 4 investigational indications. This drug has a black box warning from the FDA."}
